Welcome
Support Centre
13 May 2008 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

Submit your study protocol
[ Print-friendly version ]
Investigating the effect of vitamin K supplementation on markers of bone turnover and bone density in adolescents and adults with cystic fibrosis
ISRCTN ISRCTN14200211
ClinicalTrials.gov identifier
Public title Investigating the effect of vitamin K supplementation on markers of bone turnover and bone density in adolescents and adults with cystic fibrosis
Scientific title
Acronym N/A
Serial number at source vit K 2006
Study hypothesis Vitamin K supplementation improves markers of bone turnover and bone density in adolescents and adults with cystic fibrosis (CF).
Ethics approval Ethics approval received from the Wandsworth Research Ethics Committee on the 11th August 2006 (protocol v4), 18th May 2007 (amendments protocol v5) and 3rd August 2007 (amendments protocol v6).
Study design Randomised double-blind placebo-controlled study
Countries of recruitment United Kingdom
Disease/condition/study domain Bone health in cystic fibrosis
Participants - inclusion criteria 1. Patients with a diagnosis of CF (positive sweat test or genotype testing)
2. Patients aged greater than 16 years (post pubertal-stage IV Tanner), either sex
3. Patients are pancreatic insufficient (i.e. with a positive faecal elastase test, and requiring pancreatic enzyme supplementation)
4. No evidence of overt liver disease (not on ursodeoxycholic acid)
Participants - exclusion criteria 1. Patients already taking vitamin K supplementation
2. Patients with osteoporosis or osteopaenia and taking bisphosphonates
3. Patients with abnormally low vitamin D levels (less than 30 µg)
4. Patients on maintenance oral corticosteroids
5. Patients who are considered to have very sedentary lifestyle or follow a rigorous exercise training programme
6. Patients with overt liver disease
7. Patients who do not consent to participate
8. Patients with a life expectancy of less than 12 months
9. Patients who are non-compliant with maintenance therapies
Anticipated start date 02/01/2007
Anticipated end date 09/02/2009
Status of trial Ongoing
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 40
Interventions 1. 10 mg of menadiol phosphate (water soluble form of vitamin K) once daily (o.d.) orally for 12 months
2. Matching placebo for 12 months

Total duration of treatment and follow-up: 12 months for both arms.
Primary outcome measure(s) The between-groups difference in the ratio of undercarboxylated osteocalcin to total osteocalcin, measured prior to supplementation starting and at the end of the 12 months supplementation.
Secondary outcome measure(s) The between-group differences in:
1. Total osteocalcin
2. Undercarboxylated osteocalcin
3. N Terminal X (marker of bone resorption)
4. Bone specific alkaline phosphatase
5. Serum vitamin D
6. Calcium
7. Dual energy x-ray absorptiometry (DEXA) scan z and t scores of lumbar spine and femoral neck (scores adjusted for age, height and sex)

Measured prior to supplementation starting and at the end of the 12 months supplementation.
Sources of funding Barts and the London NHS Trust (UK) - Internally funded from Nursing, Midwifering and Allied Health Profession research grant
Trial website
Publications
Contact name Dr  Lieske  Kuitert
  Address Department of Respiratory Medicine
London Chest Hospital
Bonner Road
  City/town London
  Zip/Postcode E2 9JX
  Country United Kingdom
Sponsor Barts and the London NHS Trust (UK)
  Address Research and Development Department
24 - 26 Walden Street
Whitechapel
  City/town London
  Zip/Postcode E1 2AN
  Country United Kingdom
  Sponsor website: http://www.bartsandthelondon.org.uk/
Date applied 02/04/2008
Last edited 09/05/2008
Date ISRCTN assigned 09/05/2008
News
28 Sept 2007: 2007 Update of NHS Trusts Clinical Trials Register now available online
Aug 2007: Searches on ISRCTN register can now be bookmarked
Jul 2007: Patient information material field added to the ISRCTN Register
May 2007: WHO launches the International Clinical Trials Registry Search Portal
3 Apr 2007: Q&As regarding trial registration in the UK
4 Dec 2006: Trials taking place in the UK collated in 'Gateway'

© ISRCTN


BioMed Central